glp 1 agonist for type 1 diabetes How GLP-1 Receptor Agonists Evolved from to Weight Loss Treatments Glucagon-like peptide-1 receptor agonists and
Description
and Mol

In clinical trials, liraglutide showed a placebo-corrected weight loss of around 5%, semaglutide 12%, and tirzepatide 18% [23]

Mol Metab 2023;68:101665.ArticlePubMedPMC 29

These agents mimic the biological action of the native incretin hormone GLP-1 but are structurally modified to resist degradation by the enzyme dipeptidyl peptidase 4 (DPP-4), thereby extending their half-life and duration of action (Zheng et al., 2024

doi: 10.1111/jnc.15521 24 RodeAKOBuusTBMrazVAl-JaberiFAHLopezDVFordSLet al

How GLP-1 use affects food habits GLP-1 use is driving noticeable shifts in eating habits, from healthier food choices to reduced overall consumption
